Feedstuffs is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Elanco, Tonisity partner on gut enhancing swine products

NPB Pigs Eating.JPG
Companies enter distribution and promotion agreement for Tonisity Px and Tonisity PxW.

Elanco Animal Health and Tonisity International, an animal health and nutrition company based in Ireland, have entered into a distribution and promotion agreement in respect of Tonisity’s novel, gut enhancing porcine products, Tonisity Px and Tonisity PxW.

Under the terms of the agreement, Elanco will act as exclusive distributor of Tonisity’s Swine Products in Brazil, Belgium, Denmark, France, Germany, Norway, Portugal, Spain, Sweden, and The Netherlands. As exclusive distributor, Elanco will be responsible for marketing, promotion and distribution and sale of the Swine Products in these markets. The specific transition timelines to a distribution via Elanco in early 2023 are currently being elaborated. Both Elanco and Tonisity have agreed to explore collaboration opportunities in other markets, when appropriate. The addition of Tonisity’s Swine Products to Elanco’s portfolio fits perfectly with Elanco’s strategy of promoting the intestinal health of animals, improving their overall health and leading to a more efficient production, providing its customers an innovative product portfolio.

Tonisity Px is a patented isotonic protein drink that directly feeds the intestinal cells of livestock, such as piglets. This accelerates and increases the absorption of all nutrients into the body of the animal. Tonisity Px is administered to piglets in the first week of life and around weaning and is voluntarily consumed even by newborn piglets. The result is higher weight gain, lower mortality and less need for medications for these animals – all producing a high return on investment for producers.

Tonisity is dedicated to research and has completed nearly 200 swine trials throughout the world. In studies examining pre-weaning morality, Tonisity Px reduced pre-weaning mortality by 20% which amounts to an extra pig for every three litters. Administration of Tonisity Px also resulted in higher weaning weights and 3 kg extra weight at finisher stage, with an improved feed conversion rate. This technology results in a reliable 3:1 return on investment (5:5-1 in a recent China study) at weaning and 5-6:1 at finishing.

Tonisity PxW contains the same key bioactives aimed at nourishing the intestine and is delivered through ordinary waterlines to newly-weaned pigs, with no extra labor required. The weaning period and the first 2-3 weeks after weaning are a major danger period for pigs. Often, newly-weaned pigs struggle to maintain sufficient water intake. Reduced water intake correlates to reduced feed intake, which creates a growth lag and contributes to morbidity and mortality.

Tonisity PxW improves water intake by up to 2 times in the first few days after weaning. Pigs given Tonisity PxW for five days post-weaning had a 36% reduction in post-weaning mortality and a 18% decrease in post-weaning morbidity. Tonisity PxW has also been shown to improve end-Nursery weights by 300 grams when compared to a competitor product. Trials indicate that the return on investment on Tonisity PxW is a minimum of 4.5:1.

The Tonisity Products can also be given to pigs of any age at other stress points in production, such as weaning, before and after transport, and for sows, at farrowing or during lactation. While both products have been demonstrated to improve the performance of healthy pigs, trial data also shows that they are particularly useful in support of dehydration and recovery from illnesses such as Porcine Reproductive and Respiratory Syndrome and Porcine Epidemic Diarrhea Virus.

Tonisity’s Swine Products are patented in all key markets and are currently being sold in Europe, Africa, Asia, North America, South America and Australia. Currently, the Isotonic Swine Products are manufactured in Ireland.

“Elanco has a long history of research in intestinal integrity. We believe this agreement with Tonisity perfectly fits our strategy and complements Elanco’s value offer,” said Pablo Muniesa, Elanco International species lead for swine and general manager Iberia. “We will continue supporting our swine customers with innovative products, services, and knowledge so they can maintain intestinal integrity in their herds and contributing to produce safe, abundant, and affordable food to our growing population.”

Arie Halpern, chief executive officer of Tonisity, commented: “As food security continues to be a major concern across the globe, Tonisity is thrilled to be partnering with Elanco, one of the largest and most respected animal health multinationals in the world. Tonisity’s Px and PxW products are revolutionary in their ability to dramatically improve the health of swine, while generating more revenues and saving costs for food producers across the world. Further, with the recent ban in the European Union of zinc oxide as an antimicrobial in pig feed, the need for our unique products in that important market is growing by the day. We are confident that this partnership will act as a catalyst in making Tonisity a leading global animal health company.”

TAGS: Business
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.